Group I ribozymes can repair mutant RNAs via trans-splicing. Unfortunately,
substrate specificity is quite low for the trans-splicing reaction catalyz
ed by the group I ribozyme from Tetrahymena thermophila. We have used a sys
tematic approach based on biochemical knowledge of the function of the Tetr
ahymena ribozyme to optimize its ability to discriminate against nonspecifi
c substrates in vitro. Ribozyme derivatives that combine a mutation which i
ndirectly slows down the rate of the chemical cleavage step by weakening gu
anosine binding with additional mutations that weaken substrate binding hav
e greatly enhanced specificity with short oligonucleotide substrates and an
mRNA fragment derived from the p53 gene. Moreover, compared to the wild-ty
pe ribozyme, reaction of a more specific ribozyme with targeted substrates
is much less sensitive to the presence of nonspecific RNA competitors. Thes
e results demonstrate how a detailed understanding of the biochemistry of a
catalytic RNA can facilitate the design of customized ribozymes with impro
ved properties for therapeutic applications.